Advertisement

Navigate this Article


 

Promega PROTAC蛋白降解研究操作说明书Vendor   

蛋白质降解是维持细胞蛋白质内稳态的重要机制。当无功能蛋白的溶酶体和1或蛋白酶体清除途径失效时,会形成聚合物,而这些聚合物可导致机体内潜发各种疾病,包括帕金森病和阿尔茨海默病。另一方面,通过影响细胞降解机制进而使靶蛋白发生明显降解,可作为一种治疗癌症、自身免疫和神经疾病等疾病新型治疗方法,拥有巨大的应用前景。相较于传统的小分子疗法,蛋白降解药物具有多种优势,例如其可扩大“可靶向"蛋白质组的使用范围,延长药代动力学持续时间;同时蛋白降解药物以催化的模式起作用,因此使用其进行治疗时,给予较低给药剂量即可达到较好效果。分子胶和蛋白降解靶向嵌合体( PROTAC)是该类新型小分子降解药物(如LYTAC. PHOTAC. PROTAC. 分子胶、AUTAC.疏水标记物)中最具有代表性的药物。

Please login or register for free to view full text
Copyright: © 2020 The Authors; exclusive licensee Bio-protocol LLC.
Q&A

If you have any questions/comments about this protocol, you are highly recommended to post here. We will invite the authors of this protocol as well as some of its users to address your questions/comments. To make it easier for them to help you, you are encouraged to post your data including images for the troubleshooting.

If you have any questions/comments about this protocol, you are highly recommended to post here. We will invite the authors of this protocol as well as some of its users to address your questions/comments. To make it easier for them to help you, you are encouraged to post your data including images for the troubleshooting.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.